Label-free high-throughput screening via mass spectrometry: A single cystathionine quantitative method for multiple applications

Assay and Drug Development Technologies

Volumn 7, Issue 5, 2009, Pages 495-506

  Holt, Tom G ^a   Choi, Bernard K ^a   Geoghagen, Neil S ^a   Jensen, Kristian K ^a   Luo, Qi ^a   Lamarr, William A ^b   Makara, Gergely M ^a   Malkowitz, Lorraine ^a   Ozbal, Can C ^b   Xiong, Yusheng ^a   Dufresne, Claude ^a   Luo, Ming Juan ^a  

^a BioTrove Inc ^*

^b BioTrove Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CYSTATHIONINE; CYSTATHIONINE BETA SYNTHASE;

ARTICLE; CELL ASSAY; CONTROLLED STUDY; DERIVATIZATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; ENZYME SUBSTRATE; EXPLANT; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIBRARY; LIVER; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS;

ANIMALS; CALIBRATION; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTATHIONINE; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; INDICATORS AND REAGENTS; KINETICS; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 70450284551     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2009.0200     Document Type: Article

References (28)

1. Gauglitz G, Proll G: Strategies for label-free optical detection. Adv Biochem Eng/Biotechnol 2008;109:395-432.
2. Minor LK: Label-free cell-based functional assays. Comb Chem High Throughput Screen 2008;11:573-580.
3. Shiau AK, Massari ME, Ozbal CC: Back to basics: label-free technologies for small molecule screening. Comb Chem High Throughput Screen 2008;11:231-237.
4. Greis KD: Mass spectrometry for enzyme assays and inhibitor screening: an emerging application in pharmaceutical research. Mass Spectrom Rev 2007;26:324-339.
5. Forbes CD, Toth JG, Ozbal CC, La Marr WA, Pendleton JA, Rocks S, et al.: Highthroughput mass spectrometry screening for inhibitors of phosphatidylserine decarboxylase. J Biomol Screen 2007;12:628-634.
6. Ozbal CC, LaMarr WA, Linton JR, Green DF, Katz A, Morrison TB, et al.: High throughput screening via mass spectrometry: a case study using acetylcholinesterase. Assay Drug Dev Technol 2004;2:373-381.
7. Quercia AK, LaMarr WA, Myung J, Ozbal CC, Landro JA, Lumb KJ: Highthroughput screening by mass spectrometry: comparison with the scintillation proximity assay with a focused-fi le screen of AKT1/PKBa. J Biomol Screen 2007;12:473-480.
8. Soulard P, McLaughlin M, Stevens J, Connolly B, Coli R, Wang L, et al.: Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry. Anal Chim Acta 2008;627:105-111.
9. Deng G, Sanyal G: Applications of mass spectrometry in early stages of target based drug discovery. J Pharm Biomed Anal 2006;40:528-538.
10. Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho P-I, Zhang J-H, et al.: Mass spectrometric techniques for label-free high-throughput screening in drug discovery. Anal Chem 2007;79:8207-8213.
11. Jhee K-H, Kruger WD: The role of cystathionine b-synthase in homocysteine metabolism. Antioxid Redox Signal 2005;7:813-822.
12. Li L, Moore PK: Putative biological roles of hydrogen sulfi de in health and disease: a breath of not so fresh air? Trends Pharmacol Sci 2008;29:84-90.
13. Szabo C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007;6:917-935.
14. Miles EW, Kraus JP: Cystathionine b-synthase: structure, function, regulation, and location of homocystinuria-causing mutations. J Biol Chem 2004;279:29871-29874.
15. Banerjee R, Zou C-G: Redox regulation and reaction mechanism of human cystathionine- b-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys 2005;433:144-156.
16. Wang L, Jhee K-H, Hua X, DiBello PM, Jacobsen DW, Kruger WD: Modulation of cystathionine b-synthase level regulates total serum homocysteine in mice. Circ Res 2004;94:1318-1324.
17. Shan X, Kruger WD: Correction of disease-causing CBS mutations in yeast. Nat Genet 1998;19:91-93.
18. Kraus JP: Cystathionine b-synthase (human). Methods Enzymol 1987;143: 388-394.
19. Ohmori S, Nakata K, Nishihara K, Yamamoto S, Kawase M, Tsuboi S: Sensitive determination of cystathionine and assays for cystathionine b- and g-lyase, as well as cystathionine b-synthase, using high-performance liquid chromatography. J Chromatogr Biomed Appl 1992;574:35-40.
20. Bajad SU, Lu W, Kimball EH, Yuan J, Peterson C, Rabinowitz JD: Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. J Chromatogr A 2006;1125: 76-88.
21. Lu W, Kimball E, Rabinowitz JD: A high-performance liquid chromatographytandem mass spectrometry method for quantitation of nitrogen-containing intracellular metabolites. J Am Soc Mass Spectrom 2006;17:37-50.
22. Zhang J, Chung T, Oldenburg K: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
23. Frank N, Kent JO, Meier M, Kraus JP: Purifi cation and characterization of the wild type and truncated human cystathionine b-synthase enzymes expressed in E. coli. Arch Biochem Biophys 2008;470:64-72.
24. Taoka S, Ohja S, Shan X, Kruger WD, Banerjee R: Evidence for heme-mediated redox regulation of human cystathionine b-synthase activity. J Biol Chem 1998;273:25179-25184.
25. Janosik M, Kery V, Gaustadnes M, MacLean KN, Kraus JP: Regulation of human cystathionine b-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry 2001;40:10625-10633.
26. Jensen KK, Geoghagen NS, Jin L, Holt TG, Luo Q, Malkowitz L, et al.: Pharmacologic activation and genetic manipulation of cystathionine â synthase alter circulating levels of homocysteine and hydrogen sulfi de in mice. J Biol Chem submitted for publication 2009.
27. Annesley TM: Ion suppression in mass spectrometry. Clin Chem 2003;49: 1041-1044.
28. LaVallie ER, Dorner AJ, Burczynski ME: Use of ex vivo systems for biomarker discovery. Curr Opin Pharmacol 2008;8:647-653.